97 related articles for article (PubMed ID: 17572717)
1. How much GMP do we need to infuse contaminated HPC and DLI products?
Forte L; Gardiner N; O'Connell B; McCann SR
Bone Marrow Transplant; 2007 Aug; 40(4):389-90. PubMed ID: 17572717
[No Abstract] [Full Text] [Related]
2. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
[TBL] [Abstract][Full Text] [Related]
3. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
4. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
[TBL] [Abstract][Full Text] [Related]
5. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
6. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
8. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hepatitis B virus transmission from an infected stem cell donor.
Piekarska A; Zaucha JM; Hellmann A; McDonald GB
Bone Marrow Transplant; 2007 Aug; 40(4):399-400. PubMed ID: 17572708
[No Abstract] [Full Text] [Related]
10. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
[TBL] [Abstract][Full Text] [Related]
11. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
12. [Umbilical blood is a source of hemopoietic stem cells for transplantation].
Rumiantsev SA; Maĭorova OA; Rumiantsev AG
Ter Arkh; 2007; 79(7):53-7. PubMed ID: 17802791
[TBL] [Abstract][Full Text] [Related]
13. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
Dykes JH; Toporski J; Juliusson G; Békássy AN; Lenhoff S; Lindmark A; Scheding S
Transfusion; 2007 Nov; 47(11):2134-42. PubMed ID: 17958543
[TBL] [Abstract][Full Text] [Related]
14. Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation.
Meyer-Monard S; Passweg J; Siegler U; Kalberer C; Koehl U; Rovó A; Halter J; Stern M; Heim D; Alois Gratwohl JR; Tichelli A
Transfusion; 2009 Feb; 49(2):362-71. PubMed ID: 19389215
[TBL] [Abstract][Full Text] [Related]
15. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
16. Optimum storage conditions for cord blood-derived hematopoietic progenitor cells prior to isolation.
Moldenhauer A; Wolf J; Habermann G; Genter G; Kiesewetter H; Salama A
Bone Marrow Transplant; 2007 Nov; 40(9):837-42. PubMed ID: 17768391
[TBL] [Abstract][Full Text] [Related]
17. [Cryopreservation of hematopoietic cells: evolution of concepts].
Rizzoli V; Mangoni L; Costi D; Caramatti C
Riv Emoter Immunoematol; 1985; 32(2):129-34. PubMed ID: 4089465
[No Abstract] [Full Text] [Related]
18. T-cell therapy after hematopoietic stem cell transplantation.
Kennedy-Nasser AA; Brenner MK
Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
[TBL] [Abstract][Full Text] [Related]
19. Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.
Hartwig UF; Nonn M; Khan S; Link I; Huber C; Herr W
Biol Blood Marrow Transplant; 2008 Jan; 14(1):99-109. PubMed ID: 18158966
[TBL] [Abstract][Full Text] [Related]
20. Bacteremias in children receiving hemopoietic SCT.
Castagnola E; Faraci M; Moroni C; Bandettini R; Caruso S; Bagnasco F; Caviglia I; Natalizia AR; de Fazio V; Morreale G; Lanino E; Dini G; Haupt R
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S104-6. PubMed ID: 18545230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]